Subclavian vein repair in patients with an ipsilateral arteriovenous fistula.
Management of subclavian vein occlusive disease in persons with an ipsilateral arteriovenous fistula can be challenging. From July 1991 to May 1993, nine patients underwent direct exploration and repair of an obstructed subclavian vein following medial claviculectomy. Eight patients had polytetrafluoroethylene (PTFE) grafts; one patient had a Brescia-Cimino fistula. Intractable arm edema was the major symptom in five of eight. The site of the occlusive disease ranged from the midsubclavian vein to the proximal innominate vein. Pathology varied from a focal occluding web to a long segment of intimal fibroplasia. Five veins were occluded; four were stenotic. Surgical procedures consisted of endovenectomy and vein patch (four), endovenectomy and PTFE patch (one), resection of a focal stricture with end-to-end anastomosis (two), resection with PTFE interposition (one), and end-to-end internal jugular to subclavian vein transposition (one). Postoperative contrast venograms revealed a patent subclavian vein in eight of eight patients. One patient died postoperatively from unrelated causes; two patients died with a functioning fistula 8 and 12 months, respectively, after surgery. Two grafts were removed for infection and one deteriorated graft was abandoned because of repeated thrombosis. Only three of nine original grafts are currently in use, including one in which the ipsilateral subclavian vein rethrombosed. Although stent placement may now be the preferred treatment for subclavian vein stenosis, vein repair may still have a role in the treatment of subclavian vein occlusion, particularly in patients with a Brescia-Cimino fistula.
Gradman
W S
WS
Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, Calif.
Bressman
P
P
Sernaque
J D
JD
D000328:Adult; D000368:Aged; D000714:Anastomosis, Surgical / Q000379:methods; D001132:Arm / Q000098:blood supply; D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects; D001807:Blood Vessel Prosthesis; D016121:Brachiocephalic Veins / Q000473:pathology; D002405:Catheterization, Central Venous / Q000009:adverse effects; D002968:Clavicle / Q000601:surgery; D003251:Constriction, Pathologic / Q000473:pathology / Q000601:surgery; D004487:Edema / Q000628:therapy; D005260:Female; D006801:Humans; D007601:Jugular Veins / Q000601:surgery; D008297:Male; D008875:Middle Aged; D011138:Polytetrafluoroethylene; D016459:Prosthesis-Related Infections / Q000601:surgery; D013350:Subclavian Vein / Q000473:pathology / Q000601:surgery*; D015996:Survival Rate; D013927:Thrombosis / Q000601:surgery; D014652:Vascular Diseases / Q000473:pathology / Q000601:surgery
D011138:Polytetrafluoroethylene